Tyra Biosciences, Inc. TYRA Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -36.9%-9.8pp | -39.8%-8.2pp | -34.7%-6.1pp | -31.2%-4.9pp | -27%-3.4pp | |
| Return on invested capital | -53.2%+8.1pp | -59.7%-8.9pp | -51.5%+20.7pp | -49.4%+15.3pp | -61.3%+54.6pp | |
| Liquidity | ||||||
| Current ratio | 20.5×-2.3× | 14.7×-9.1× | 17.7×-11.8× | 21.9×-14.5× | 22.8×-22.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $6.28+15.1% | $4.35-27.5% | $4.70-23.6% | $5.07-20.8% | $5.45-27.0% | |
| Valuation | ||||||
| Market capitalization | $2.06B+318% | $1.4B+99.5% | $745.63M-46.1% | $517.95M-44.8% | $493.74M-42.4% | |
| Price / book | 5.3×+3.8× | 5.4×+3.4× | 2.7×-1.2× | 1.7×-0.8× | 1.5×-0.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Tyra Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Tyra Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.